Partner

Theatinerstraße 16
Munich
80333

+49 892 102 960

Patent star 2020/21

Top 250 Women in IP 2020

English
German


Jurisdictions:

Germany

Practice areas:

Patent office proceedings
Patent prosecution
Patent strategy & counseling

Industry sectors:

Biotechnology
Chemistry
Life sciences
Pharmaceutical


Sandra Pohlman is co-founder and partner of df-mp. She heads the firm’s large and diversified biotechnology and pharmaceuticals practice group together with Dr. Dörries. A main part of her practice is oppositions and prosecution before the European Patent Office, where she has consistently obtained favorable results for her clients.

She has served as lead counsel in notable opposition cases relating to patents for blockbuster drugs and groundbreaking technologies including, more recently, Tecfidera®, Tysabri®, and attacking and defending CRISPR patents. In IAM 1000: The World's Leading Patent Practitioners 2013-2020, Ms. Pohlman was recommended for her expertise in patent prosecution and invalidity actions including the following comments about her skills: "She displays a matchless knowledge of her law, her writing is brilliant, and she is hugely responsive", and: "She can handle high-pressure briefs with a cool head and is the first choice for North American law firms". Managing Intellectual Property lists Sandra Pohlman, as IP Star for Germany in their MIP Handbook 2014-2020. She was listed as one of the Top 250 Women in IP (worldwide) by Managing IP in 2016-2020.

 

Year Joined Firm: 2000

Education/Alumni:

  • Biology, University of Vermont, U.S.A
  • Jurist Doctor Degree (magna cum laude) from the National Law Center of the George Washington University in Washington, DC, U.S.A

Network Memberships: GRUR, VPP, ECTA, INTA, AIPLA

 

Last updated 30th October 2020